0
A Call to Action: Overcoming Anxiety Through Active Coping
Joseph E. LeDoux, Ph.D.; Jack M. Gorman, M.D.
Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study
Jonathan Davidson, M.D.; Teri Pearlstein, M.D.; Peter Londborg, M.D.; Kathleen T. Brady, M.D.; Barbara Rothbaum, Ph.D.; Jon Bell, M.D.; Richard Maddock, M.D.; Mark T. Hegel, Ph.D.; Gail Farfel, Ph.D.
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Randall D. Marshall, M.D.; Katherine L. Beebe, Ph.D.; Mary Oldham, Ph.D.; Rocco Zaninelli, M.D.
An Effect-Size Analysis of the Relative Efficacy and Tolerability of Serotonin Selective Reuptake Inhibitors for Panic Disorder
Michael W. Otto, Ph.D.; Kimberly S. Tuby, B.A.; Robert A. Gould, Ph.D.; Renée Y.S. McLean, B.A.; Mark H. Pollack, M.D.
Emotion-Focused Psychotherapy for Patients With Panic Disorder
M. Katherine Shear, M.D.; Patricia Houck, M.S.H.; Catherine Greeno, Ph.D.; Sophia Masters, B.S.
Impact of Generalized Social Anxiety Disorder in Managed Care
David J. Katzelnick, M.D.; Kenneth A. Kobak, Ph.D.; Thomas DeLeire, Ph.D.; Henry J. Henk, M.S.; John H. Greist, M.D.; Jonathan R.T. Davidson, M.D.; Franklin R. Schneier, M.D.; Murray B. Stein, M.D.; Cindy P. Helstad, Ph.D.
Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex
Nora D. Volkow, M.D.; Linda Chang, M.D.; Gene-Jack Wang, M.D.; Joanna S. Fowler, Ph.D.; Yu-Sin Ding, Ph.D.; Mark Sedler, M.D.; Jean Logan, Ph.D.; Dinko Franceschi, M.D.; John Gatley, Ph.D.; Robert Hitzemann, Ph.D.; Andrew Gifford, Ph.D.; Christopher Wong, M.S.; Naomi Pappas, M.S.
Developmental Sequence From Disruptive Behavior Diagnosis to Adolescent Alcohol Dependence
Samuel Kuperman, M.D.; Steven S. Schlosser, M.A.T.; John R. Kramer, Ph.D.; Kathleen Bucholz, Ph.D.; Victor Hesselbrock, Ph.D.; Theodore Reich, M.D.; Wendy Reich, Ph.D.
Ethnic Disparities in Unmet Need for Alcoholism, Drug Abuse, and Mental Health Care
Kenneth Wells, M.D., M.P.H.; Ruth Klap, Ph.D.; Alan Koike, M.D.; Cathy Sherbourne, Ph.D.
Long-Term Outcome of Cognitive Behavior Therapy Versus Relaxation Therapy for Chronic Fatigue Syndrome: A 5-Year Follow-Up Study
Alicia Deale, Ph.D.; Kaneez Husain, B.Sc.; Trudie Chalder, Ph.D.; Simon Wessely, M.D.
An Open-Label Trial of Evidence-Based Cognitive Behavior Therapy for Nightmares and Insomnia in Crime Victims With PTSD
Barry Krakow, M.D.; Lisa Johnston, M.A., M.P.H.; Dominic Melendrez, PSGT; Michael Hollifield, M.D.; Teddy D. Warner, Ph.D.; Debie Chavez-Kennedy; Margaret J. Herlan, M.A.
Multinuclear Magnetic Resonance Spectroscopy Studies of Brain Purines in Major Depression
Perry F. Renshaw, M.D., Ph.D.; Aimee M. Parow, B.S.; Fuyuki Hirashima, B.S.; Yong Ke, Ph.D.; Constance M. Moore, Ph.D.; Blaise deB. Frederick, Ph.D.; Maurizio Fava, M.D.; John Hennen, Ph.D.; Bruce M. Cohen, M.D., Ph.D.
A Study of Women Who Stalk
Rosemary Purcell, B.A., M.Psych.; Michele Pathé, M.B.B.S., F.R.A.N.Z.C.P.; Paul E. Mullen, M.B.B.S., D.Sc., F.R.C.Psych.
Prevalence of Body Dysmorphic Disorder in a Community Sample of Women
Michael W. Otto, Ph.D.; Sabine Wilhelm, Ph.D.; Lee S. Cohen, M.D.; Bernard L. Harlow, Ph.D.
Successful Multimodality Treatment of Severe Behavioral Disturbance in a Patient With Advanced Huntington’s Disease
David M. Blass, M.D.; Martin Steinberg, M.D.; Iracema Leroi, M.D.; Constantine G. Lyketsos, M.D., M.H.S.
Defective Relationship Between Subjective Experience and Behavior in Schizophrenia
Jean-Marie Danion, M.D.; Erick Gokalsing, M.D.; Philippe Robert, M.D., Ph.D.; Marilyne Massin-Krauss, M.Sc.; Elisabeth Bacon, Ph.D.
Neurophysiological Evidence of Corollary Discharge Dysfunction in Schizophrenia
Judith M. Ford, Ph.D.; Daniel H. Mathalon, Ph.D., M.D.; Theda Heinks, Dipl.-Psych.; Sontine Kalba, B.A.; William O. Faustman, Ph.D.; Walton T. Roth, M.D.
A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia
Wayne S. Fenton, M.D.; Faith Dickerson, Ph.D.; John Boronow, M.D.; Joseph R. Hibbeln, M.D.; Michael Knable, D.O.
Influence of Serotonin-Transporter-Linked Promoter Region Polymorphism on Platelet Activation in Geriatric Depression
Ellen M. Whyte, M.D.; Bruce G. Pollock, M.D., Ph.D.; William R. Wagner, Ph.D.; Benoit H. Mulsant, M.D.; Robert E. Ferrell, Ph.D.; Sati Mazumdar, Ph.D.; Charles F. Reynolds, III, M.D.
Antidepressant Treatment of Depression in the Finnish General Population
Tanja Laukkala, M.D., Ph.D.; Erkki Isometsä, M.D., Ph.D.; Juha Hämäläinen, M.D., M.A.(Biol.); Martti Heikkinen, M.D., Ph.D.; Sari Lindeman, M.D., Ph.D., M.Sc.(Psychol.); Hillevi Aro, M.D., Ph.D.
Pindolol Augmentation of Selective Serotonin Reuptake Inhibitors: PET Evidence That the Dose Used in Clinical Trials Is Too Low
Eugenii A. Rabiner, F.C.Psych.(S.A.); Zubin Bhagwagar, M.R.C.Psych.; Roger N. Gunn, Ph.D.; Peter A. Sargent, M.R.C.Psych.; Christopher J. Bench, M.R.C.Psych.; Philip J. Cowen, F.R.C.Psych.; Paul M. Grasby, M.R.C.Psych.
Cortisol Feedback During the HPA Quiescent Period in Patients With Major Depression
Joel A. Posener, M.D.; Charles DeBattista, D.M.H., M.D.; Gordon H. Williams, M.D.; Alan F. Schatzberg, M.D.
Bright Light Therapy for Schizoaffective Disorder
DAN A. OREN, M.D.; JOSEPH F. CUBELLS, M.D., Ph.D.; SIMONE LITSCH
Imipramine Toxicity and Terbinafine
MARK L. TEITELBAUM, M.D.; VINCENT EARL PEARSON, Pharm.D., B.C.P.S.
Continuation of Clozapine After Priapism
RAJSHREE N. BONGALE, M.D.; JANET L. TEKELL, M.D.; GAYLE E. HARAGUCHI, M.D., Ph.D.; ERIKA M. NAVARRO, M.D.
Olanzapine-Induced Priapism
DOUGLAS A. SONGER, M.D.; JAMES C. BARCLAY, M.D.
Venlafaxine- and Trazodone-Induced Serotonin Syndrome
ROBERT E. McCUE, M.D.; MICHEL JOSEPH, M.D.
ECT for Psychotic Depression Associated With a Brain Tumor
CHRISTIAN G. KOHLER, M.D.; MARC BUROCK, M.S.E.E.
Venlafaxine and Breast-Feeding
VICTORIA HENDRICK, M.D.; LORI ALTSHULER, M.D.; AMY WERTHEIMER, B.A.; WILLIAM A. DUNN, M.S., F.T.S.-A.B.F.T., T.C.(N.R.C.C.)
End-of-Life Care Content in Textbooks
MICHAEL W. RABOW, M.D.; STEPHEN J. McPHEE, M.D.
Psychiatric Pharmacists
SARA GRIMSLEY AUGUSTIN, Pharm.D., B.C.P.P.; TALIA PUZANTIAN, Pharm.D., B.C.P.P.; CHARLES F. CALEY, Pharm.D., B.C.P.P.; PATRICIA A. MARKEN, Pharm.D., B.C.P.P.; ANN L. RICHARDS, Pharm.D., B.C.P.P.; GARY M. LEVIN, Pharm.D., B.C.P.P.
Psychotherapy by Nonphysicians
C. PETER ROSENBAUM, M.D.
Drs. Beahrs and Gutheil Reply
JOHN O. BEAHRS, M.D.; THOMAS G. GUTHEIL, M.D.
Drs. Chabrol and Corraze Reply
HENRI CHABROL, M.D., Ph.D.; JACQUES CORRAZE, M.D., Ph.D.
Psychosocial Treatment for Schizophrenia
TOSHIAKI A. FURUKAWA, M.D., Ph.D.
Tribute to Lasègue
WALTER VANDEREYCKEN, M.D., Ph.D.
Dr. Bustillo and Colleagues Reply
JUAN R. BUSTILLO, M.D.; JOHN LAURIELLO, M.D.; SAMUEL KEITH, M.D.
Research on Women
ARNOLD ROBBINS, M.D.
Dr. Stotland Replies
NADA L. STOTLAND, M.D., M.P.H.
Drugs on the Internet
MICHAEL P. BOGENSCHUTZ, M.D.
Adolescents With Schizophrenia
MARINA MYLES-WORSLEY, Ph.D.
Drs. Halpern and Pope Reply
JOHN H. HALPERN, M.D.; HARRISON G. POPE, Jr., M.D.
Spectacular Happiness
TODD GRISWOLD, M.D.
Thinks…
ROBERT MICHELS, M.D.
Kinship Theory
PETER D. KRAMER, M.D.
Husbands and Wives
Richard G. Druss, M.D.